Minerva Neurosciences (NERV) Enterprise Value Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Minerva Neurosciences 215.11 Mn 215.11 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -348.91%
Dec 31, 2025 -283.94%
Sep 30, 2025 53.48%
Jun 30, 2025 50.46%
Mar 31, 2025 50.20%
Dec 31, 2024 47.67%
Sep 30, 2024 43.35%
Jun 30, 2024 40.30%
Mar 31, 2024 3.21%
Dec 31, 2023 -18.34%
Sep 30, 2023 -16.58%
Jun 30, 2023 -4.10%
Mar 31, 2023 34.46%
Dec 31, 2022 35.94%
Sep 30, 2022 38.62%
Jun 30, 2022 32.92%
Mar 31, 2022 31.40%
Dec 31, 2021 -112.53%
Sep 30, 2021 -101.40%
Jun 30, 2021 -129.71%
Mar 31, 2021 -166.26%
Dec 31, 2020 44.48%
Sep 30, 2020 14.18%
Jun 30, 2020 -15.77%
Mar 31, 2020 1.86%
Dec 31, 2019 8.90%
Sep 30, 2019 56.51%
Jun 30, 2019 59.38%
Mar 31, 2019 32.10%
Dec 31, 2018 60.73%
Sep 30, 2018 9.67%
Jun 30, 2018 11.32%
Mar 31, 2018 -173.36%
Dec 31, 2017 -54.45%
Sep 30, 2017 -5.34%
Jun 30, 2017 20.08%
Mar 31, 2017 62.94%
Dec 31, 2016 -157.67%
Sep 30, 2016 -145.02%
Jun 30, 2016 -174.28%
Mar 31, 2016 14.48%
Dec 31, 2015 -73.65%
Sep 30, 2015 -58.58%
Jun 30, 2015 -7,272.04%
Mar 31, 2015 -2,337.90%
Dec 31, 2014 -919.94%
Sep 30, 2014 -2,048.55%
Jun 30, 2014 67.61%